Peptides & Peptide Synthesis Products
Fmoc-Asp(OBzl)-OH

Fmoc-Asp(OBzl)-OH

Fmoc-Asp-OH

Fmoc-Asp-OH

Fmoc-Asp(OcHex)-OH

Catalog No: 41061
(2S)-4-cyclohexyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid, CAS: 130304-80-2, MW: 437.48, Formula: C25H27NO6
$15.00
SKU
41061

Fast shipping · Pay by card or purchase order · Bulk quantities available — contact us

Fmoc-Asp(OcHex)-OH
Nα-Fmoc-L-aspartic acid β-cyclohexyl ester; (2S)-4-cyclohexyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid

An aspartic acid derivative whose side-chain ester was designed to suppress aspartimide formation. The secondary cyclohexyl ester is more hindered than a benzyl or methyl ester, and it was introduced for aspartyl peptides precisely because it cyclizes to the aspartimide far less readily under both the acidic and the basic treatments of a synthesis.

It is an acid-stable, Boc/benzyl-compatible group: unaffected by piperidine and by TFA, and removed by anhydrous HF or trifluoromethanesulfonic acid, the conditions of a Boc final deprotection. With Nα-Fmoc, this derivative serves Fmoc or hybrid syntheses: in an Fmoc/tBu synthesis the peptide is therefore released with the side chain still esterified, which is useful when that is wanted and a drawback otherwise; where the side chain is to come off with the peptide and aspartimide is the worry, Fmoc-Asp(OtBu)-OH with 0.1 M HOBt in the piperidine solution, or a bulkier tert-alkyl ester, is the usual route.

Applications

  • Aspartyl peptides where aspartimide formation has to be kept low
  • Fmoc or hybrid syntheses with a strong-acid (HF or TFMSA) final deprotection
  • Asp-Gly and other aspartimide-prone sequences

Storage
Store refrigerated (2–8 °C) in a tightly closed container, and let it reach room temperature before opening.

References

  1. Tam JP et al. Cyclohexyl ester as a new protecting group for aspartyl peptides to minimize aspartimide formation in acidic and basic treatments. Tetrahedron Letters 1979, 20, 4033–4036. doi:10.1016/s0040-4039(01)86496-0
  2. Mergler M et al. The aspartimide problem in Fmoc‐based SPPS. Part I. Journal of Peptide Science 2003, 9, 36–46. doi:10.1002/psc.430
  3. Sakakibara S et al. A New Method for Releasing Oxytocin from Fully-protected Nona-peptides Using Anhydrous Hydrogen Fluoride. Bulletin of the Chemical Society of Japan 1965, 38, 1412–1413. doi:10.1246/bcsj.38.1412

For research use only. Not for human or veterinary use.

More Information
Catalog Number 41061
CAS 130304-80-2
M.W. 437.48
Formula C25H27NO6
IUPAC Name (2S)-4-cyclohexyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid
InChIKey OCMZRMNYEXIKQI-QFIPXVFZSA-N
InChI InChI=1S/C25H27NO6/c27-23(32-16-8-2-1-3-9-16)14-22(24(28)29)26-25(30)31-15-21-19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h4-7,10-13,16,21-22H,1-3,8-9,14-15H2,(H,26,30)(H,28,29)/t22-/m0/s1
SMILES C1CCC(CC1)OC(=O)C[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

The current Safety Data Sheet for Fmoc-Asp(OcHex)-OH (Catalog No: 41061).

Download PDF

The Certificate of Analysis for each lot of Fmoc-Asp(OcHex)-OH (Catalog No: 41061). Enter the lot number printed on the product label.

Write Your Own Review
You're reviewing:Fmoc-Asp(OcHex)-OH